Showing results (511-520 of 530) with videos related to
Sort By:
Pageof 53
The Review of Scientific Instruments|February 5, 2020
Installation and commissioning of the ion source systems for the new spallation neutron source 2.5 MeV injectorR F Welton, B X Han, M P Stockli, et al.Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Corticospinal tract risk modifies motor recovery after minimally invasive surgery for intracerebral hemorrhage: a secondary analysis of MISTIE-IIIOlivia N Murray, David A Jenkins, Nathan Walborn, et al.Clinical Journal of Oncology Nursing|February 11, 2025
Effects of Virtual Reality on Pain, Stress, and Affect in an Outpatient Chemotherapy Infusion Clinic: A Randomized Controlled TrialCody C Stansel, Alexander R McLeod, Shubham Gulati, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 13, 2001
Detrimental effects of complement activation in hemorrhagic shockJ G Younger, N Sasaki, M D Waite, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimenV Westeel, N Murray, K Gelmon, et al.Oncogene|June 19, 2026
Early induction of the Rho-GEF ECT2 drives MEK/ERK oncogenic signaling in pancreatic ductal adenocarcinomaDania Al-Qasrawi, Nayya N Murray, Ryan A Argo, et al.Journal of the National Cancer Institute|December 10, 1997
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working CadreM A Tucker, N Murray, E G Shaw, et al.The Review of Scientific Instruments|March 5, 2008
H(-) ion source developments at the SNSR F Welton, M P Stockli, S N Murray, et al.The Review of Scientific Instruments|March 3, 2010
The continued development of the Spallation Neutron Source external antenna H- ion sourceR F Welton, J Carmichael, N J Desai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology GroupN Murray, R B Livingston, F A Shepherd, et al.Pageof 53